Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review

World Journal of Gastroenterology

Volumn 21, Issue 45, 2015, Pages 12896-12953

  Fiorino, Sirio ^a   Bacchi Reggiani, Letizia ^b   De Biase, Dario ^c   Fornelli, Adele ^d   Masetti, Michele ^d   Tura, Andrea ^e   Grizzi, Fabio ^f   Zanello, Matteo ^d   Mastrangelo, Laura ^d   Lombardi, Raffaele ^d   Acquaviva, Giorgia ^c   Di Tommaso, Luca ^f   Bondi, Arrigo ^d   Visani, Michela ^c   Sabbatani, Sergio ^b   Pontoriero, Laura ^g   Fabbri, Carlo ^d   Cuppini, Andrea ^a   Pession, Annalisa ^c   Jovine, Elio ^d  

^a Ospedale di Budrio   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d MAGGIORE HOSPITAL   (Italy)

^e CNR   (Italy)

^f HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^g CT ASP   (Italy)

Author keywords

Cancer; Cholangiocarcinoma; Extra hepatic malignancies; Hepatitis C virus; Hepatocellular carcinoma; Neoplasm; Pancreatic cancer; Risk factors

Indexed keywords

BILE DUCT CARCINOMA; BREAST CANCER; CANCER RISK; COCHRANE LIBRARY; DISEASE ASSOCIATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY CANCER; LIVER CELL CARCINOMA; LIVER HISTOLOGY; MEDLINE; MOUTH CANCER; PANCREAS CANCER; REVIEW; SKIN CANCER; SYSTEMATIC REVIEW; THYROID CANCER; HEPACIVIRUS; LIVER TUMOR; NEOPLASMS; PATHOGENICITY; RISK ASSESSMENT; RISK FACTOR; VIROLOGY;

CARCINOMA, HEPATOCELLULAR; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER NEOPLASMS; NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 84949033162     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i45.12896     Document Type: Review

References (268)

1. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61: S45-S57 [PMID: 25086286 DOI: 10. 1016/j. jhep. 2014. 07. 027]
2. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13: 2436-2441 [PMID: 17552026]
3. Younossi ZM, Kanwal F, Saab S, Brown KA, El-Serag HB, Kim WR, Ahmed A, Kugelmas M, Gordon SC. The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther 2014; 39: 518-531 [PMID: 24461160 DOI: 10. 1111/apt. 12625]
4. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Opolon P. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999; 42: 2204-2212 [PMID: 10524695 DOI: 10. 1002/1529-0131]
5. Mariotto S, Ferrari S, Monaco S. HCV-related central and peripheral nervous system demyelinating disorders. Inflamm Allergy Drug Targets 2014; 13: 299-304 [PMID: 25198705]
6. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, André C, Voisin MC, Intrator L, Zafrani ES, Duval J, Dhumeaux D. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169-173 [PMID: 7810933]
7. Ko HM, Hernandez-Prera JC, Zhu H, Dikman SH, Sidhu HK, Ward SC, Thung SN. Morphologic features of extrahepatic manifestations of hepatitis C virus infection. Clin Dev Immunol 2012; 2012: 740138 [PMID: 22919404 DOI: 10. 1155/2012/740138]
8. Crovatto M, Pozzato G, Zorat F, Pussini E, Nascimben F, Baracetti S, Grando MG, Mazzaro C, Reitano M, Modolo ML, Martelli P, Spada A, Santini G. Peripheral blood neutrophils from hepatitis C virusinfected patients are replication sites of the virus. Haematologica 2000; 85: 356-361 [PMID: 10756359]
9. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Bréchot C. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992; 15: 382-386 [PMID: 1332999]
10. Sansonno D, Lauletta G, Montrone M, Grandaliano G, Schena FP, Dammacco F. Hepatitis C virus RNA and core protein in kidney glomerular and tubular structures isolated with laser capture microdissection. Clin Exp Immunol 2005; 140: 498-506 [PMID: 15932511 DOI: 10. 1111/j. 1365-2249. 2005. 02778. x]
11. Arrieta JJ, Rodriguez-Inigo E, Casqueiro M, Bartolomé J, Manzarbeitia F, Herrero M, Pardo M, Carreno V. Detection of hepatitis C virus replication by In situ hybridization in epithelial cells of anti-hepatitis C virus-positive patients with and without oral lichen planus. Hepatology 2000; 32: 97-103 [PMID: 10869295 DOI: 10. 1053/jhep. 2000. 8533]
12. Kurokawa M, Hidaka T, Sasaki H, Nishikata I, Morishita K, Setoyama M. Analysis of hepatitis C virus (HCV) RNA in the lesions of lichen planus in patients with chronic hepatitis C: detection of anti-genomic-as well as genomic-strand HCV RNAs in lichen planus lesions. J Dermatol Sci 2003; 32: 65-70 [PMID: 12788531]
13. Carrozzo M, Quadri R, Latorre P, Pentenero M, Paganin S, Bertolusso G, Gandolfo S, Negro F. Molecular evidence that the hepatitis C virus replicates in the oral mucosa. J Hepatol 2002; 37: 364-369 [PMID: 12175632]
14. Toussirot E, Le Huédé G, Mougin C, Balblanc JC, Bettinger D, Wendling D. Presence of hepatitis C virus RNA in the salivary glands of patients with Sjögren's syndrome and hepatitis C virus infection. J Rheumatol 2002; 29: 2382-2385 [PMID: 12415596]
15. De Vita S, De Re V, Sansonno D, Sorrentino D, Corte RL, Pivetta B, Gasparotto D, Racanelli V, Marzotto A, Labombarda A, Gloghini A, Ferraccioli G, Monteverde A, Carbone A, Dammacco F, Boiocchi M. Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis. Hepatology 2000; 31: 182-189 [PMID: 10613744 DOI: 10. 1002/hep. 510310127]
16. Yan FM, Chen AS, Hao F, Zhao XP, Gu CH, Zhao LB, Yang DL, Hao LJ. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol 2000; 6: 805-811 [PMID: 11819700]
17. Akdo?an M, Mert A, Tabak F, ?zdemir S, Sonsuz A, Sent?rk H. Hepatitis C infection in non-Hodgkin's lymphoma. Turk J Gastroenterol 1998; 1: 73-75
18. Arcaini L, Paulli M, Boveri E, Vallisa D, Bernuzzi P, Orlandi E, Incardona P, Brusamolino E, Passamonti F, Burcheri S, Schena C, Pascutto C, Cavanna L, Magrini U, Lazzarino M. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer 2004; 100: 107-115 [PMID: 14692030 DOI: 10. 1002/cncr. 11893]
19. Arcaini L, Varettoni M, Boveri E, Orlandi E, Rattotti S, Zibellini S, Merli M, Lucioni M, Rizzi S, Gotti M, Morello L, Pascutto C, Paulli M. Distinctive clinical and histological features of Waldenström' s macroglobulinemia and splenic marginal zone lymphoma. Clin Lymphoma Myeloma Leuk 2011; 11: 103-105 [PMID: 21454204 DOI: 10. 3816/CLML. 2011. n. 020]
20. Arican A, Sengezer T, Bozdayi M, Bozkaya H, Uçgül E, Dinçol D, Uzunalimo?lu O. Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma. Med Oncol 2000; 17: 123-126 [PMID: 10871818 DOI: 10. 1007/ BF02796207]
21. Avilés A, Valdez L, Halabe J, Neri N, Nellen H, Huerta-Guzmán J, Nambo MJ. No association between lymphoma and hepatitis C virus. Med Oncol 2003; 20: 165-168 [PMID: 12835519 DOI: 10. 1385/MO:20:2:165]
22. Bauduer F, Katsahian S, Blanchard Y, Oui B, Capdupuy C, Renoux M. Descriptive epidemiology of non-Hodgkin lymphomas in a southwestern French hematology center: absence of significant relationship with hepatitis C virus infection. Hematol Cell Ther 1999; 41: 191-193 [PMID: 10651117]
23. Besson C, Canioni D, Lepage E, Pol S, Morel P, Lederlin P, Van Hoof A, Tilly H, Gaulard P, Coiffier B, Gisselbrecht C, Brousse N, Reyes F, Hermine O. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs. J Clin Oncol 2006; 24: 953-960 [PMID: 16418500 DOI: 10. 1200/ JCO. 2005. 01. 5016]
24. Bianco E, Marcucci F, Mele A, Musto P, Cotichini R, Sanpaolo MG, Iannitto E, De Renzo A, Martino B, Specchia G, Montanaro M, Barbui AM, Nieddu R, Pagano L, Rapicetta M, Franceschi S, Mandelli F, Pulsoni A. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study. Haematologica 2004; 89: 70-76 [PMID: 14754608]
25. Boffetta P, Armstrong B, Linet M, Kasten C, Cozen W, Hartge P. Consortia in cancer epidemiology: lessons from InterLymph. Cancer Epidemiol Biomarkers Prev 2007; 16: 197-199 [PMID: 17301250 DOI: 10. 1158/1055-9965]
26. Bronowicki JP, Bineau C, Feugier P, Hermine O, Brousse N, Oberti F, Rousselet MC, Dharancy S, Gaulard P, Flejou JF, Cazals-Hatem D, Labouyrie E. Primary lymphoma of the liver: clinical-pathological features and relationship with HCV infection in French patients. Hepatology 2003; 37: 781-787 [PMID: 12668970 DOI: 10. 1053/ jhep. 2003. 50121]
27. Catassi C, Fabiani E, Coppa GV, Gabrielli A, Centurioni R, Leoni P, Barbato M, Viola F, Martelli M, De Renzo A, Rotoli B, Bertolani P, Federico M, Carroccio A, Iannitto E, Baldassarre M, Guarini A, Guariso G, Favaretto G, Caramaschi P, Ambrosetti A. [High prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma at the onset. Preliminary results of an Italian multicenter study]. Recenti Prog Med 1998; 89: 63-67 [PMID: 9558907]
28. Chindamo MC, Spector N, Segadas JA, Pimenta G, Vanderborght B, Morais JC, Milito C, Moraes Coelho HS. Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphomas. Oncol Rep 2002; 9: 657-659 [PMID: 11956646]
29. Chuang SS, Liao YL, Chang ST, Hsieh YC, Kuo SY, Lu CL, Hwang WS, Lin IH, Tsao CJ, Huang WT. Hepatitis C virus infection is significantly associated with malignant lymphoma in Taiwan, particularly with nodal and splenic marginal zone lymphomas. J Clin Pathol 2010; 63: 595-598 [PMID: 20530156 DOI: 10. 1136/ jcp. 2010. 076810]
30. Ohmuro H, Tomino Y, Tsushima Y, Shimizu M, Kuramoto T, Koide H. Elevation of serum IgA1 levels in patients with diabetic nephropathy. Nephron 1993; 63: 355 [PMID: 8446278 DOI: 10. 1007/s12185-008-0086-3]
31. Collier JD, Zanke B, Moore M, Kessler G, Krajden M, Shepherd F, Heathcote J. No association between hepatitis C and B-cell lymphoma. Hepatology 1999; 29: 1259-1261 [PMID: 10094973 DOI: 10. 1002/hep. 510290422]
32. Cowgill KD, Loffredo CA, Eissa SA, Mokhtar N, Abdel-Hamid M, Fahmy A, Strickland GT. Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt. Int J Epidemiol 2004; 33: 1034-1039 [PMID: 15155696 DOI: 10. 1093/ije/dyh183]
33. Cucuianu A, Patiu M, Duma M, Basarab C, Soritau O, Bojan A, Vasilache A, Mates M, Petrov L. Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients. Br J Haematol 1999; 107: 353-356 [PMID: 10583224]
34. Dal Maso L, Talamini R, Montella M, Crovatto M, Franceschi S. Hepatitis B and C viruses and Hodgkin lymphoma: a case-control study from Northern and Southern Italy. Haematologica 2004; 89: ELT17 [PMID: 15533850]
35. De Renzo A, Persico E, de Marino F, di Giacomo Russo G, Notaro R, di Grazia C, Picardi M, Santoro L, Torella R, Rotoli B, Persico M. High prevalence of hepatitis G virus infection in Hodgkin's disease and B-cell lymphoproliferative disorders: absence of correlation with hepatitis C virus infection. Haematologica 2002; 87: 714-718; discussion 718 [PMID: 12091122]
36. De Rosa G, Gobbo ML, De Renzo A, Notaro R, Garofalo S, Grimaldi M, Apuzzo A, Chiurazzi F, Picardi M, Matarazzo M, Rotoli B. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 1997; 55: 77-82 [PMID: 9209002 DOI: 10. 1002/(SICI)1096-8652( 199706)55:2]
37. de Sanjose S, Nieters A, Goedert JJ, Domingo-Domenech E, Fernandez de Sevilla A, Bosch R, Herrera P, Domingo A, Petit J, Bosch X, Kallinowski B. Role of hepatitis C virus infection in malignant lymphoma in Spain. Int J Cancer 2004; 111: 81-85 [PMID: 15185347 DOI: 10. 1002/ijc. 11727]
38. De Vita S, Zagonel V, Russo A, Rupolo M, Cannizzaro R, Chiara G, Boiocchi M, Carbone A, Franceschi S. Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma. Br J Cancer 1998; 77: 2032-2035 [PMID: 9667688]
39. Domingo JM, Romero MS, Palomera L, Gutiérrez M. [Hepatitis C virus infection in patients with non Hodgkin's lymphoma]. Med Clin (Barc) 2001; 117: 638 [PMID: 11714475]
40. Duberg AS, Nordström M, Törner A, Reichard O, Strauss R, Janzon R, Bäck E, Ekdahl K. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology 2005; 41: 652-659 [PMID: 15723449 DOI: 10. 1002/hep. 20608]
41. Ellenrieder V, Weidenbach H, Frickhofen N, Michel D, Prümmer O, Klatt S, Bernas O, Mertens T, Adler G, Beckh K. HCV and HGV in B-cell non-Hodgkin's lymphoma. J Hepatol 1998; 28: 34-39 [PMID: 9537861]
42. El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002; 36: 1439-1445 [PMID: 12447870 DOI: 10. 1053/ jhep. 2002. 37191]
43. Engels EA, Chatterjee N, Cerhan JR, Davis S, Cozen W, Severson RK, Whitby D, Colt JS, Hartge P. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer 2004; 111: 76-80 [PMID: 15185346 DOI: 10. 1002/ijc. 20021]
44. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, Greco F, Capochiani E, Mazzoni A. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392-394 [PMID: 7803287]
45. Ferri C, La Civita L, Caracciolo F, Zignego AL. Non-Hodgkin' s lymphoma: possible role of hepatitis C virus. JAMA 1994; 272: 355-356 [PMID: 8028163]
46. Franceschi S, Lise M, Trépo C, Berthillon P, Chuang SC, Nieters A, Travis RC, Vermeulen R, Overvad K, Tjønneland A, Olsen A, Bergmann MM, Boeing H, Kaaks R, Becker N, Trichopoulou A, Lagiou P, Bamia C, Palli D, Sieri S, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita B, Peeters PH, Rodríguez L, Barroso LL, Dorronsoro M, Sánchez MJ, Navarro C, Barricarte A, Regnér S, Borgquist S, Melin B, Hallmans G, Khaw KT, Wareham N, Rinaldi S, Hainaut P, Riboli E, Vineis P. Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 2011; 20: 208-214 [PMID: 21098651]
47. Gasparotto D, De Re V, Boiocchi M. Hepatitis C virus, B-cell proliferation and lymphomas. Leuk Lymphoma 2002; 43: 747-751 [PMID: 12153160 DOI: 10. 1080/10428190290016845]
48. Gasztonyi B, Pár A, Szomor A, Battyány I, Nagy A, Kereskai L, Losonczy H, Mózsik G. Hepatitis C virus infection associated with B-cell non-Hodgkin's lymphoma in Hungarian patients. Br J Haematol 2000; 110: 497-498 [PMID: 11023295]
49. Gentile G, Mele A, Monarco B, Vitale A, Pulsoni A, Visani G, Castelli G, Rapicetta M, Verani P, Martino P, Mandelli F. Hepatitis B and C viruses, human T-cell lymphotropic virus types I and II, and leukemias: a case-control study. The Italian Leukemia Study Group. Cancer Epidemiol Biomarkers Prev 1996; 5: 227-230 [PMID: 8833624]
50. Genvresse I, Späth-Schwalbe E, Meisel H, Kaufmann O, Krüger DH, Possinger K. Primary hepatic or splenic diffuse large B-cell lymphoma and hepatitis C virus infection: a non-fortuitous association? Ann Hematol 2000; 79: 530-532 [PMID: 11043427]
51. Germanidis G, Haioun C, Pourquier J, Gaulard P, Pawlotsky JM, Dhumeaux D, Reyes F. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. Blood 1999; 93: 1778-1779 [PMID: 10084815]
52. Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007; 297: 2010-2017 [PMID: 17488966 DOI: 10. 1001/jama. 297. 18. 2010]
53. Gisbert JP, García-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003; 125: 1723-1732 [PMID: 14724825]
54. Goldman L, Ezzat S, Mokhtar N, Abdel-Hamid A, Fowler N, Gouda I, Eissa SA, Abdel-Hamid M, Loffredo CA. Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes. Cancer Causes Control 2009; 20: 981-987 [PMID: 19263231 DOI: 10. 1007/ s10552-009-9316-0]
55. Grudeva-Popova J, Nenova I, Mateva N, Ananoshtev N, Popov V, Atanasova M. Non-Hodgkin lymphomas and carrier state of viral hepatitis B and C. J BUON 2000; 18: 239-244 [PMID: 23613411]
56. Guida M, D'Elia G, Benvestito S, Casamassima A, Micelli G, Quaranta M, Moschetta R, De Lena M, Lorusso V. Hepatitis C virus infection in patients with B-cell lymphoproliferative disorders. Leukemia 2002; 16: 2162-2163 [PMID: 12357374 DOI: 10. 1038/ sj. leu. 2402626]
57. Hanley J, Jarvis L, Simmonds P, Parker A, Ludlam C. HCV and non-Hodgkin lymphoma. Lancet 1996; 347: 1339 [PMID: 8622540]
58. Harakati MS, Abualkhair OA, Al-Knawy BA. Hepatitis C Virus infection in Saudi Arab patients with B-cell non-Hodgkin's lymphoma. Saudi Med J 2000; 21: 755-758 [PMID: 11423889]
59. Hausfater P, Cacoub P, Sterkers Y, Thibault V, Amoura Z, Nguyen L, Ghillani P, Leblond V, Piette JC. Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1, 576 patients in France. Am J Hematol 2001; 67: 168-171 [PMID: 11391713 DOI: 10. 1002/ajh. 1101]
60. Imai Y, Ohsawa M, Tanaka H, Tamura S, Sugawara H, Kuyama J, Fukuda K, Yonezawa T, Matsuzawa Y. High prevalence of HCV infection in patients with B-cell non-Hodgkin's lymphoma: comparison with birth cohort-and sex-matched blood donors in a Japanese population. Hepatology 2002; 35: 974-976 [PMID: 11915049 DOI: 10. 1053/jhep. 2002. 32149]
61. Iwata H, Matsuo K, Takeuchi K, Kishi Y, Murashige N, Kami M. High incidences of malignant lymphoma in patients infected with hepatitis B or hepatitis C virus. Haematologica 2004; 89: 368-370 [PMID: 15020283]
62. Izumi T, Sasaki R, Miura Y, Okamoto H. Primary hepatosplenic lymphoma: association with hepatitis C virus infection. Blood 1996; 87: 5380-5381 [PMID: 8652854]
63. Izumi T, Sasaki R, Tsunoda S, Akutsu M, Okamoto H, Miura Y. B cell malignancy and hepatitis C virus infection. Leukemia 1997; 11 Suppl 3: 516-518 [PMID: 9209442]
64. Karavattathayyil SJ, Kalkeri G, Liu HJ, Gaglio P, Garry RF, Krause JR, Dash S. Detection of hepatitis C virus RNA sequences in B-cell non-Hodgkin lymphoma. Am J Clin Pathol 2000; 113: 391-398 [PMID: 10705820 DOI: 10. 1309/REV9-FDTM-5NGCHBWY]
65. Kaya H, Polat MF, Erdem F, Gündogdu M. Prevalence of hepatitis C virus and hepatitis G virus in patients with non-Hodgkin' s lymphoma. Clin Lab Haematol 2002; 24: 107-110 [PMID: 11985556]
66. King PD, Wilkes JD, Diaz-Arias AA. Hepatitis C virus infection in non-Hodgkin's lymphoma. Clin Lab Haematol 1998; 20: 107-110 [PMID: 9681221]
67. Kuniyoshi M, Nakamuta M, Sakai H, Enjoji M, Kinukawa N, Kotoh K, Fukutomi M, Yokota M, Nishi H, Iwamoto H, Uike N, Nishimura J, Inaba S, Maeda Y, Nawata H, Muta K. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol 2001; 16: 215-219 [PMID: 11207904]
68. Luppi M, Longo G, Ferrari MG, Barozzi P, Marasca R, Morselli M, Valenti C, Mascia T, Vandelli L, Vallisa D, Cavanna L, Torelli G. Clinico-pathological characterization of hepatitis C virusrelated B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia. Ann Oncol 1998; 9: 495-498 [PMID: 9653489]
69. Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, Sorio R, Bortolus R, Crovatto M, Santini G, Tiribelli C, Sasso F, Masutti R, Pozzato G. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544-550 [PMID: 8790157]
70. McColl MD, Singer IO, Tait RC, McNeil IR, Cumming RL, Hogg RB. The role of hepatitis C virus in the aetiology of non-Hodgkins lymphoma-a regional association? Leuk Lymphoma 1997; 26: 127-130 [PMID: 9250797 DOI: 10. 3109/10428199709109167]
71. Mele A, Pulsoni A, Bianco E, Musto P, Szklo A, Sanpaolo MG, Iannitto E, De Renzo A, Martino B, Liso V, Andrizzi C, Pusterla S, Dore F, Maresca M, Rapicetta M, Marcucci F, Mandelli F, Franceschi S. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 2003; 102: 996-999 [PMID: 12714514 DOI: 10. 1182/blood-2002-10-3230]
72. Mizorogi F, Hiramoto J, Nozato A, Takekuma Y, Nagayama K, Tanaka T, Takagi K. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. Intern Med 2000; 39: 112-117 [PMID: 10732826]
73. Montella M, Crispo A, de Bellis G, Izzo F, Frigeri F, Ronga D, Spada O, Mettivier V, Tamburini M, Cuomo O. HCV and cancer: a case-control study in a high-endemic area. Liver 2001; 21: 335-341 [PMID: 11589770]
74. Montella M, Crispo A, Frigeri F, Ronga D, Tridente V, De Marco M, Fabbrocini G, Spada O, Mettivier V, Tamburini M. HCV and tumors correlated with immune system: a case-control study in an area of hyperendemicity. Leuk Res 2001; 25: 775-781 [PMID: 11489471]
75. Morton LM, Engels EA, Holford TR, Leaderer B, Zhang Y, Zahm SH, Boyle P, Zhang B, Flynn S, Tallini G, Owens PH, Zheng T. Hepatitis C virus and risk of non-Hodgkin lymphoma: a populationbased case-control study among Connecticut women. Cancer Epidemiol Biomarkers Prev 2004; 13: 425-430 [PMID: 15006919]
76. Musto P, Dell'Olio M, Carotenuto M, Mangia A, Andriulli A. Hepatitis C virus infection: a new bridge between hematologists and gastroenterologists? Blood 1996; 88: 752-754 [PMID: 8695825]
77. Nicolosi Guidicelli S, Lopez-Guillermo A, Falcone U, Conconi A, Christinat A, Rodriguez-Abreu D, Grisanti S, Lobetti-Bodoni C, Piffaretti JC, Johnson PW, Mombelli G, Cerny A, Montserrat E, Cavalli F, Zucca E. Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study Group. Hematol Oncol 2012; 30: 137-142 [PMID: 22105737 DOI: 10. 1002/hon. 1015]
78. Nieters A, Kallinowski B, Brennan P, Ott M, Maynadié M, Benavente Y, Foretova L, Cocco PL, Staines A, Vornanen M, Whitby D, Boffetta P, Becker N, De Sanjosé S. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology 2006; 131: 1879-1886 [PMID: 17087949 DOI: 10. 1053/j. gastro. 2006. 09. 019]
79. Ogino H, Satomura Y, Unoura M, Yoshida T, Oguri H, Kaneko S, Kobayashi K. Hepatitis B, C and G virus infection in patients with lymphoproliferative disorders. Hepatol Res 1999; 14: 187-194
80. Ohsawa M, Shingu N, Miwa H, Yoshihara H, Kubo M, Tsukuma H, Teshima H, Hashimoto M, Aozasa K. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. Int J Cancer 1999; 80: 237-239 [PMID: 9935205 DOI: 10. 1002/(SICI)1097-0215 (19990118)80:2]
81. Omland LH, Jepsen P, Krarup H, Christensen PB, Weis N, Nielsen L, Obel N, Sørensen HT, Stuver SO. Liver cancer and non-Hodgkin lymphoma in hepatitis C virus-infected patients: results from the DANVIR cohort study. Int J Cancer 2012; 130: 2310-2317 [PMID: 21780099 DOI: 10. 1002/ijc. 26283]
82. Panovska I, Georgievski B, Stojanovic A, Cevreska L, Efremov DG. Low prevalence of chronic hepatitis C virus infection in B-cell non-Hodgkin's lymphoma patients from a population with a high prevalence of healthy hepatitis c virus carriers. Br J Haematol 2000; 109: 249-250 [PMID: 10848806]
83. Park SC, Jeong SH, Kim J, Han CJ, Kim YC, Choi KS, Cho JH, Lee M, Jung HH, Ki SS, Chang YH, Lee SS, Park YH, Lee KH. High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea. J Med Virol 2008; 80: 960-966 [PMID: 18428141 DOI: 10. 1002/jmv. 21168]
84. Paydas S, Kiliç B, Sahin B, Bu?dayci R. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey. Br J Cancer 1999; 80: 1303-1305 [PMID: 10424729 DOI: 10. 1038/sj. bjc. 6690522]
85. Pioltelli P, Gargantini L, Cassi E, Santoleri L, Bellati G, Magliano EM, Morra E. Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients. Lombart Study Group of HCV-Lymphoma. Am J Hematol 2000; 64: 95-100 [PMID: 10814987 DOI: 10. 1002/(SICI)1096-8652(200006) 64:2]
86. Pioltelli P, Zehender G, Monti G, Monteverde A, Galli M. HCV and non-Hodgkin lymphoma. Lancet 1996; 347: 624-625 [PMID: 8596360]
87. Prati D, Zanella A, De Mattei C, Farma E, Boschetti C, Sirchia G, Venegoni L, Berti E. Chronic hepatitis c virus infection and primary cutaneous B-cell lymphoma. Br J Haematol 1999; 105: 841 [PMID: 10354158]
88. Rabkin CS, Tess BH, Christianson RE, Wright WE, Waters DJ, Alter HJ, Van Den Berg BJ. Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 2002; 99: 4240-4242 [PMID: 12010836 DOI: 10. 1182/blood-2002-01-0226]
89. Ramos-Casals M, Trejo O, García-Carrasco M, Cervera R, De La Red G, Gil V, López-Guillermo A, Ingelmo M, Font J. Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma. J Rheumatol 2004; 31: 495-499 [PMID: 14994393]
90. Salem Z, Nuwaiyri-Salti N, Ramlawi F, Ramia S. Hepatitis C virus infection in Lebanese patients with B-cell non-Hodgkin's lymphoma. Eur J Epidemiol 2003; 18: 251-253 [PMID: 12800950 DOI: 10. 1023/A:1023380316098]
91. Sansonno D, De Vita S, Cornacchiulo V, Carbone A, Boiocchi M, Dammacco F. Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 1996; 88: 4638-4645 [PMID: 8977256]
92. Schöllkopf C, Smedby KE, Hjalgrim H, Rostgaard K, Panum I, Vinner L, Chang ET, Glimelius B, Porwit A, Sundström C, Hansen M, Adami HO, Melbye M. Hepatitis C infection and risk of malignant lymphoma. Int J Cancer 2008; 122: 1885-1890 [PMID: 18271005 DOI: 10. 1002/ijc. 23416]
93. Sève P, Renaudier P, Sasco AJ, Dumontet C, Salles G, Coiffier B, Zoulim F, Broussolle C, Trépo C. Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma: a cross-sectional study in Lyon, France. Eur J Gastroenterol Hepatol 2004; 16: 1361-1365 [PMID: 15618846]
94. Shariff S, Yoshida EM, Gascoyne RD, Le N, Connors JM, Middleton PJ, Shenkier TN. Hepatitis C infection and B-cell non-Hodgkin's lymphoma in British Columbia: a cross-sectional analysis. Ann Oncol 1999; 10: 961-964 [PMID: 10509159]
95. Shirin H, Davidovitz Y, Avni Y, Petchenko P, Krepel Z, Bruck R, Meytes D. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Isr Med Assoc J 2002; 4: 24-27 [PMID: 11802304]
96. Silvestri F, Barillari G, Fanin R, Pipan C, Falasca E, Salmaso F, Zaja F, Infanti L, Patriarca F, Botta GA, Baccarani M. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica 1997; 82: 314-317 [PMID: 9234578]
97. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, Falasca E, Botta GA, Baccarani M. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296-4301 [PMID: 8639788]
98. Singer IO, Cumming RL, Hogg RB. Is hepatitis C associated with non-Hodgkin's lymphoma? Leuk Lymphoma 1997; 26: 633-634 [PMID: 9389373 DOI: 10. 3109/10428199709050902]
99. Sonmez M, Bektas O, Yilmaz M, Durmus A, Akdogan E, Topbas M, Erturk M, Ovali E, Omay SB. The relation of lymphoma and hepatitis B virus/hepatitis C virus infections in the region of East Black Sea, Turkey. Tumori 2002; 93: 536-539 [PMID: 18338485]
100. Spinelli JJ, Lai AS, Krajden M, Andonov A, Gascoyne RD, Connors JM, Brooks-Wilson AR, Gallagher RP. Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, Canada. Int J Cancer 2008; 122: 630-633 [PMID: 17935132 DOI: 10. 1002/ijc. 23105]
101. Talamini R, Montella M, Crovatto M, Dal Maso L, Crispo A, Negri E, Spina M, Pinto A, Carbone A, Franceschi S. Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int J Cancer 2004; 110: 380-385 [PMID: 15095303 DOI: 10. 1002/ijc. 20137]
102. Thalen DJ, Raemaekers J, Galama J, Cooreman MP. Absence of hepatitis C virus infection in non-Hodgkin's lymphoma. Br J Haematol 1997; 96: 880-881 [PMID: 9074442]
103. Timura?lu A, Colak D, O?ünç D, Karado?an I, Undar L. Hepatitis C virus association with non-Hodgkin's lymphoma. Haematologia (Budap) 1999; 29: 301-304 [PMID: 10438070]
104. Tkoub EM, Haioun C, Pawlotsky JM, Dhumeaux D, Delchier JC. Chronic hepatitis C virus and gastric MALT lymphoma. Blood 1998; 91: 360 [PMID: 9414306]
105. Tursi A, Brandimante G, Chiarelli F, Spagnoli A, Torello M. Detection of HCV RNA in gastric mucosa-associated lymphoid tissue by in situ hybridization: evidence of a new extrahepatic localization of HCV with increased risk of gastric malt lymphoma. Am J Gastroenterol 2002; 97: 1802-1806 [PMID: 12135039 DOI: 10. 1111/j. 1572-0241. 2002. 05848. x]
106. Udomsakdi-Auewarakul C, Auewarakul P, Sukpanichnant S, Muangsup W. Hepatitis C virus infection in patients with non-Hodgkin lymphoma in Thailand. Blood 2000; 95: 3640-3641 [PMID: 10877553]
107. Vajdic CM, Grulich AE, Kaldor JM, Fritschi L, Benke G, Hughes AM, Kricker A, Turner JJ, Milliken S, Armstrong BK. Specific infections, infection-related behavior, and risk of non-Hodgkin lymphoma in adults. Cancer Epidemiol Biomarkers Prev 2006; 15: 1102-1108 [PMID: 16775166]
108. Vallisa D, Bernuzzi P, Arcaini L, Sacchi S, Callea V, Marasca R, Lazzaro A, Trabacchi E, Anselmi E, Arcari AL, Moroni C, Bertè R, Lazzarino M, Cavanna L. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J Clin Oncol 2005; 23: 468-473 [PMID: 15659492 DOI: 10. 1200/JCO. 2005. 06. 008]
109. Varma S, Menon MC, Garg A, Malhotra P, Sharma A, Chawla YK, Dhiman RK. Hepatitis C virus infection among patients with non-Hodgkin's lymphoma in northern India. Hepatol Int 2011; 5: 688-692 [PMID: 21484139 DOI: 10. 1007/s12072-010-9244-9]
110. Yamac K, Aydemir S, Ozturk G, Fen T, Senol E. Hepatitis C infection in lymphoma patients in a Turkish center. Eur J Epidemiol 2000; 16: 685 [PMID: 11078127]
111. Yoshikawa M, Imazu H, Ueda S, Tamagawa T, Yoneda S, Yamane Y, Takaya A, Fukui H, Nakano H. Prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma and multiple myeloma. A report from Japan. J Clin Gastroenterol 1997; 25: 713-714 [PMID: 9451705]
112. Yu SC, Lin CW. Early-stage splenic diffuse large B-cell lymphoma is highly associated with hepatitis C virus infection. Kaohsiung J Med Sci 2013; 29: 150-156 [PMID: 23465418 DOI: 10. 1016/ j. kjms. 2012. 08. 025]
113. Zucca E, Roggero E, Maggi-Solcà N, Conconi A, Bertoni F, Reilly I, Castelli D, Pedrinis E, Piffaretti JC, Cavalli F. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland. Haematologica 2000; 85: 147-153 [PMID: 10681721]
114. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, Qian DG, Velankar M, Nathwani BN, Fong TL. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997; 127: 423-428 [PMID: 9312998]
115. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392 [PMID: 8068936]
116. Herrinton LJ. Epidemiology of the Revised European-American Lymphoma Classification subtypes. Epidemiol Rev 1998; 20: 187-203 [PMID: 9919438]
117. Hwang JP, Suarez-Almazor ME, Torres HA, Palla SL, Huang DS, Fisch MJ, Lok AS. Hepatitis C virus screening in patients with cancer receiving chemotherapy. J Oncol Pract 2014; 10: e167-e174 [PMID: 24594679 DOI: 10. 1200/JOP. 2013. 001215]
118. Amin J, Dore GJ, O'Connell DL, Bartlett M, Tracey E, Kaldor JM, Law MG. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol 2006; 45: 197-203 [PMID: 16684579 DOI: 10. 1016/j. jhep. 2006. 02. 014]
119. Anderson LA, Pfeiffer R, Warren JL, Landgren O, Gadalla S, Berndt SI, Ricker W, Parsons R, Wheeler W, Engels EA. Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev 2008; 17: 3069-3075 [PMID: 18957521]
120. Cavanna L, Sbolli G, Tanzi E, Romanò L, Civardi G, Buscarini E, Vallisa D, Berté R, Rossi A. High prevalence of antibodies to hepatitis C virus in patients with lymphoproliferative disorders. Haematologica 1995; 80: 486-487 [PMID: 8566896]
121. Ferri C, La Civita L, Monti M, Giannini C, Cecchetti R, Caracciolo F, Longombardo G, Lombardini F, Zignego AL. Chronic hepatitis C and B-cell non-Hodgkin's lymphoma. QJM 1996; 89: 117-122 [PMID: 8729552]
122. Isikdogan A, Ayyildiz O, Dursun M, Tiftik N, Batun S, Muftuoglu E. Hepatitis C virus in patients with non-Hodgkin's lymphoma in southeastern Anatolia region of Turkey: a prospective case-control study of 119 patients. Leuk Lymphoma 2003; 44: 1745-1747 [PMID: 14692528 DOI: 10. 1080/1042819031000116724]
123. Kocaba E, Aksaray N, Alhan E, Tanyeli A, Köksal F, Yarkin F. Hepatitis B and C virus infections in Turkish children with cancer. Eur J Epidemiol 1997; 13: 869-873 [PMID: 9476814]
124. Takai S, Tsurumi H, Ando K, Kasahara S, Sawada M, Yamada T, Hara T, Fukuno K, Takahashi T, Oyama M, Onishi H, Tomita E, Takami T, Imawari M, Moriwaki H. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol 2005; 74: 158-165 [PMID: 15654908 DOI: 10. 1111/j. 1600-0609. 2004. 00376. x]
125. Teng CJ, Liu HT, Liu CY, Hsih CH, Pai JT, Gau JP, Liu JH, Chiou TJ, Hsu HC, Chen PM, Tzeng CH, Yu YB. Chronic hepatitis virus infection in patients with multiple myeloma: clinical characteristics and outcomes. Clinics (Sao Paulo) 2011; 66: 2055-2061 [PMID: 22189730]
126. Veneri D, Franchini M, Zanotti R, Frattini F, Randon F, Rinaldi M, Pizzolo G. Prevalence of hepatitis C virus infection among patients with lymphoproliferative disorders: a single center survey. Am J Hematol 2007; 82: 1031 [PMID: 17636475 DOI: 10. 1002/ ajh. 20965]
127. Yenice N, Güllük F, Arican N, Türkmen S. HCV prevalence in Hodgkin and non-Hodgkin lymphoma cases. Turk J Gastroenterol 2003; 14: 173-176 [PMID: 14655060]
128. Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006; 15: 2078-2085 [PMID: 17119031]
129. de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM, Spinelli JJ, Zheng T, Zhang Y, Franceschi S, Talamini R, Holly EA, Grulich AE, Cerhan JR, Hartge P, Cozen W, Boffetta P, Brennan P, Maynadié M, Cocco P, Bosch R, Foretova L, Staines A, Becker N, Nieters A. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 2008; 6: 451-458 [PMID: 18387498 DOI: 10. 1016/ j. cgh. 2008. 02. 011]
130. Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci 2004; 95: 745-752 [PMID: 15471561]
131. Merli M, Visco C, Spina M, Luminari S, Ferretti VV, Gotti M, Rattotti S, Fiaccadori V, Rusconi C, Targhetta C, Stelitano C, Levis A, Ambrosetti A, Rossi D, Rigacci L, D'Arco AM, Musto P, Chiappella A, Baldini L, Bonfichi M, Arcaini L. Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi. Haematologica 2014; 99: 489-496 [PMID: 24270404 DOI: 10. 3324/ haematol. 2013. 094318]
132. Pellicelli AM, Marignani M, Zoli V, Romano M, Morrone A, Nosotti L, Barbaro G, Picardi A, Gentilucci UV, Remotti D, D'Ambrosio C, Furlan C, Mecenate F, Mazzoni E, Majolino I, Villani R, Andreoli A, Barbarini G. Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma. World J Hepatol 2011; 3: 278-284 [PMID: 22125661 DOI: 10. 4254/wjh. v3. i11. 278]
133. Takeshita M, Sakai H, Okamura S, Higaki K, Oshiro Y, Uike N, Yamamoto I, Shimamatsu K, Muranaka T. Prevalence of hepatitis C virus infection in cases of B-cell lymphoma in Japan. Histopathology 2006; 48: 189-198 [PMID: 16405668 DOI: 10. 1111/ j. 1365-2559. 2005. 02311. x]
134. Caviglia GP, Sciacca C, Abate ML, Olivero A, Rosso C, Touscoz GA, Ciancio A, Rizzetto M, Smedile A. Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma. J Gastroenterol Hepatol 2015; 30: 742-747 [PMID: 25351042 DOI: 10. 1111/jgh. 12837]
135. De Renzo A, Perna F, Persico M, Notaro R, Mainolfi C, de Sio I, Ciancia G, Picardi M, Del Vecchio L, Pane F, Rotoli B. Excellent prognosis and prevalence of HCV infection of primary hepatic and splenic non-Hodgkin's lymphoma. Eur J Haematol 2008; 81: 51-57 [PMID: 18397390 DOI: 10. 1111/j. 1600-0609. 2008. 01081. x]
136. Kashyap A, Nademanee A, Molina A. Hepatitis C and B-cell lymphoma. Ann Intern Med 1998; 128: 695 [PMID: 9537949]
137. Kim JH, Bang YJ, Park BJ, Yoo T, Kim CW, Kim TY, Heo DS, Lee HS, Kim NK. Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study. Jpn J Cancer Res 2002; 93: 471-477 [PMID: 12036441]
138. Libra M, Polesel J, Russo AE, De Re V, Cinà D, Serraino D, Nicoletti F, Spandidos DA, Stivala F, Talamini R. Extrahepatic disorders of HCV infection: a distinct entity of B-cell neoplasia? Int J Oncol 2010; 36: 1331-1340 [PMID: 20428756]
139. Markovic S, Drozina G, Vovk M, Fidler-Jenko M. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients. Hepatogastroenterology 1999; 46: 2925-2930 [PMID: 10576374]
140. Musolino C, Campo S, Pollicino T, Squadrito G, Spatari G, Raimondo G. Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease. Haematologica 1996; 81: 162-164 [PMID: 8641648]
141. Okan V, Yilmaz M, Bayram A, Kis C, Cifci S, Buyukhatipoglu H, Pehlivan M. Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders. Int J Hematol 2008; 88: 403-408 [PMID: 18836791 DOI: 10. 1007/s12185-008-0175-3]
142. Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G, Sulfaro S, Franzin F, Tulissi P, Moretti M. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994; 84: 3047-3053 [PMID: 7949176]
143. Pivetti S, Novarino A, Merico F, Bertero MT, Brunetto MR, Bonino F, Caligaris-Cappio F. High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders. Br J Haematol 1996; 95: 204-211 [PMID: 8857962]
144. Salem AK. Prevalence of HCV among Yemeni patients with non-Hodgkin's lymphoma at AI-Thawra teaching hospital. Gulf J Oncolog 2009; (5): 22-29 [PMID: 20084782]
145. Sánchez Ruiz AC, Yebra Bango M, Portero F, Provencio Pulla M, Miralles Flores C, España Saz P. [Prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma]. Med Clin (Barc) 2001; 116: 333-334 [PMID: 11333763]
146. Swart A, Burns L, Mao L, Grulich AE, Amin J, O'Connell DL, Meagher NS, Randall DA, Degenhardt L, Vajdic CM. The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort study. BMJ Open 2012; 2: e001755 [PMID: 23045358 DOI: 10. 1136/ bmjopen-2012-001755]
147. Abdel Wahab M, Mostafa M, Salah T, Fouud A, Kandeel T, Elshobary M, Abd Allah OF, Elghawalby N, Sultan A, Ezzat F. Epidemiology of hilar cholangiocarcinoma in Egypt: single center study. Hepatogastroenterology 2007; 54: 1626-1631 [PMID: 18019680]
148. Kuper H, Lagiou P, Mucci LA, Tamimi R, Benetou V, Trichopoulos D. Risk factors for cholangiocarcinoma in a low risk Caucasian population. Soz Praventivmed 2001; 46: 182-185 [PMID: 11565447]
149. Lu H, Ye MQ, Thung SN, Dash S, Gerber MA. Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients. Chin Med J (Engl) 2000; 113: 1138-1141 [PMID: 11776153]
150. Mohammad-Alizadeh AH, Ghobakhlou M, Shalmani HM, Zali MR. Cholangiocarcinoma: an-eight-year experience in a tertiarycenter in Iran. Asian Pac J Cancer Prev 2012; 13: 5381-5384 [PMID: 23317187]
151. Peng NF, Li LQ, Qin X, Guo Y, Peng T, Xiao KY, Chen XG, Yang YF, Su ZX, Chen B, Su M, Qi LN. Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus. Ann Surg Oncol 2011; 18: 1258-1266 [PMID: 21207172 DOI: 10. 1245/ s10434-010-1458-5]
152. Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, Ahn YO, Shigemastu T. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 1996; 25: 933-940 [PMID: 8921477]
153. Songsivilai S, Dharakul T, Kanistanon D. Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand. Trans R Soc Trop Med Hyg 1996; 90: 505-507 [PMID: 8944256]
154. Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 1996; 11: 758-764 [PMID: 8872774]
155. Tao LY, He XD, Qu Q, Cai L, Liu W, Zhou L, Zhang SM. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China. Liver Int 2010; 30: 215-221 [PMID: 19840244 DOI: 10. 1111/j. 1478-3231. 2009. 02149. x]
156. Tomimatsu M, Ishiguro N, Taniai M, Okuda H, Saito A, Obata H, Yamamoto M, Takasaki K, Nakano M. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellularcholangiocarcinoma) in Japan. Cancer 1993; 72: 683-688 [PMID: 8192727]
157. Uenishi T, Nagano H, Marubashi S, Hayashi M, Hirokawa F, Kaibori M, Matsui K, Kubo S. The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: a multicenter analysis by Osaka Hepatic Surgery Study Group. J Surg Oncol 2014; 110: 176-181 [PMID: 24760391 DOI: 10. 1002/jso. 23611]
158. Wu TT, Levy M, Correa AM, Rosen CB, Abraham SC. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases. Cancer 2009; 115: 4564-4575 [PMID: 19670455 DOI: 10. 1002/cncr. 24471]
159. Yamamoto M, Takasaki K, Nakano M, Saito A. Minute nodular intrahepatic cholangiocarcinoma. Cancer 1998; 82: 2145-2149 [PMID: 9610693 DOI: 10. 1002/(SICI)1097-0142(19980601)82:11]
160. Yano Y, Yamamoto J, Kosuge T, Sakamoto Y, Yamasaki S, Shimada K, Ojima H, Sakamoto M, Takayama T, Makuuchi M. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol 2003; 33: 283-287 [PMID: 12913082]
161. Yin F, Chen B. Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction. Chin Med J (Engl) 1998; 111: 1068-1070 [PMID: 11263365]
162. Choi D, Lim JH, Lee KT, Lee JK, Choi SH, Heo JS, Jang KT, Lee NY, Kim S, Hong ST. Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea. J Hepatol 2006; 44: 1066-1073 [PMID: 16480786 DOI: 10. 1016/j. jhep. 2005. 11. 040]
163. Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea F, Martelli C, Savio A, Trevisi P, Nardi G. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 2001; 12: 959-964 [PMID: 11808716]
164. Parkin DM, Srivatanakul P, Khlat M, Chenvidhya D, Chotiwan P, Insiripong S, L'Abbé KA, Wild CP. Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer 1991; 48: 323-328 [PMID: 1645697]
165. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005; 128: 620-626 [PMID: 15765398]
166. Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, Hassan MM. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 2007; 102: 1016-1021 [PMID: 17324130 DOI: 10. 1111/j. 1572-0241. 2007. 01104. x]
167. Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, Takemura S, Tanaka H, Yamazaki O, Hirohashi K, Tanaka T. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 2004; 95: 592-595 [PMID: 15245596]
168. Zhou YM, Yin ZF, Yang JM, Li B, Shao WY, Xu F, Wang YL, Li DQ. Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol 2008; 14: 632-635 [PMID: 18203300]
169. Barusrux S, Nanok C, Puthisawas W, Pairojkul C, Poovorawan Y. Viral hepatitis B, C infection and genotype distribution among cholangiocarcinoma patients in northeast Thailand. Asian Pac J Cancer Prev 2012; 13 Suppl: 83-87 [PMID: 23480769]
170. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, Giordano TP. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U. S. veterans. Hepatology 2009; 49: 116-123 [PMID: 19085911 DOI: 10. 1002/hep. 22606]
171. Lee CH, Chang CJ, Lin YJ, Yeh CN, Chen MF, Hsieh SY. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer 2009; 100: 1765-1770 [PMID: 19436294 DOI: 10. 1038/sj. bjc. 6605063]
172. Portolani N, Baiocchi GL, Coniglio A, Piardi T, Grazioli L, Benetti A, Ferrari Bravo A, Giulini SM. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Ann Surg Oncol 2008; 15: 1880-1890 [PMID: 18443881 DOI: 10. 1245/s10434-008-9933-y]
173. Qu Z, Cui N, Qin M, Wu X. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas. Asia Pac J Clin Oncol 2012; 8: 83-87 [PMID: 22369448 DOI: 10. 1111/j. 1743-7563. 2011. 01466. x]
174. Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, Fiel MI, Schwartz M, Thung SN. Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 2011; 31: 49-60 [PMID: 21344350 DOI: 10. 1055/s-0031-1272839]
175. Srivatanakul P, Honjo S, Kittiwatanachot P, Jedpiyawongse A, Khuhaprema T, Miwa M. Hepatitis viruses and risk of cholangiocarcinoma in northeast Thailand. Asian Pac J Cancer Prev 2010; 11: 985-988 [PMID: 21133611]
176. Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a populationbased case-control study. Clin Gastroenterol Hepatol 2007; 5: 1221-1228 [PMID: 17689296 DOI: 10. 1016/j. cgh. 2007. 05. 020]
177. Hai S, Kubo S, Yamamoto S, Uenishi T, Tanaka H, Shuto T, Takemura S, Yamazaki O, Hirohashi K. Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Dig Surg 2005; 22: 432-439 [PMID: 16479112 DOI: 10. 1159/000091446]
178. Nuzzo G, Giuliante F, Ardito F, De Rose AM, Vellone M, Clemente G, Chiarla C, Giovannini I. Intrahepatic cholangiocarcinoma: prognostic factors after liver resection. Updates Surg 2010; 62: 11-19 [PMID: 20845096 DOI: 10. 1007/s13304-010-0007-x]
179. Tanaka M, Tanaka H, Tsukuma H, Ioka A, Oshima A, Nakahara T. Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus. J Viral Hepat 2010; 17: 742-748 [PMID: 20002305 DOI: 10. 1111/j. 1365-2893. 2009. 01243. x]
180. Torbenson M, Yeh MM, Abraham SC. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis. Am J Surg Pathol 2007; 31: 1410-1413 [PMID: 17721197 DOI: 10. 1097/ PAS. 0b013e318053d122]
181. Zuo HQ, Yan LN, Zeng Y, Yang JY, Luo HZ, Liu JW, Zhou LX. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2007; 6: 161-165 [PMID: 17374575]
182. Lee MH, Yang HI, Lu SN, Jen CL, You SL, Wang LY, Wang CH, Chen WJ, Chen CJ. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a communitybased long-term prospective study. J Infect Dis 2012; 206: 469-477 [PMID: 22811301 DOI: 10. 1093/infdis/jis385]
183. Shin HR, Oh JK, Masuyer E, Curado MP, Bouvard V, Fang YY, Wiangnon S, Sripa B, Hong ST. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci 2010; 101: 579-585 [PMID: 20085587 DOI: 10. 1111/ j. 1349-7006. 2009. 01458. x]
184. Zhou Y, Zhao Y, Li B, Huang J, Wu L, Xu D, Yang J, He J. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer 2012; 12: 289 [PMID: 22799744 DOI: 10. 1186/1471-2407-12-289]
185. Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, DeMatteo RP, Blumgart LH, Klimstra D. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 2002; 94: 2040-2046 [PMID: 11932907 DOI: 10. 1002/cncr. 10392]
186. Liu X, Zou S, Qiu F. Pathogenesis of hilar cholangiocarcinoma and infection of hepatitis virus. Zhonghua Wai Ke Za Zhi 2002; 40: 420-422 [PMID: 12139797]
187. Shirakawa H. Analysis of hepatitis C virus (HCV) genotypes in hepatocellular carcinoma. Hokkaido Igaku Zasshi 1996; 71: 677-688 [PMID: 8996837]
188. Zhang H, Tang Y, Lu X. [Detection of hepatitis B virus DNA and hepatitis C virus RNA in human hepatocellular carcinoma by polymerase chain reaction]. Zhonghua Bing Li Xue Za Zhi 1996; 25: 70-72 [PMID: 9206206]
189. Zou SQ, Liu XF, Guo RX, Li CL, Zhou XS, Zhu XG, Huang ZQ. The retrospective analysis of HBV and HCV infection in cholangiocarcinoma. Zhonghua Wai Ke Za Zhi 2003; 41: 417-419 [PMID: 12895347]
190. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 2012; 57: 69-76 [PMID: 22420979 DOI: 10. 1016/j. jhep. 2012. 02. 022]
191. Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population. J Hepatobiliary Pancreat Surg 2006; 13: 537-542 [PMID: 17139428 DOI: 10. 1007/ s00534-006-1117-1]
192. Hsing AW, Zhang M, Rashid A, McGlynn KA, Wang BS, Niwa S, Ortiz-Conde BA, Goedert JJ, Fraumeni JF, O'Brien TR, Gao YT. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer 2008; 122: 1849-1853 [PMID: 18076042 DOI: 10. 1002/ijc. 23251]
193. Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, Arase Y, Murashima N, Chayama K, Kumada H. Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000; 88: 2471-2477 [PMID: 10861422]
194. Matsumoto K, Onoyama T, Kawata S, Takeda Y, Harada K, Ikebuchi Y, Ueki M, Miura N, Yashima K, Koda M, Sakamoto T, Endo M, Horie Y, Murawaki Y. Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma. Intern Med 2014; 53: 651-654 [PMID: 24694471]
195. Perumal V, Wang J, Thuluvath P, Choti M, Torbenson M. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol 2006; 37: 1211-1216 [PMID: 16938527 DOI: 10. 1016/j. humpath. 2006. 04. 012]
196. Malaguarnera M, Gargante MP, Risino C, Ranno S, Berretta M, Cannizzaro MA, Costanzo M, Fricia T, Rampello E, Romano M. Hepatitis C virus in elderly cancer patients. Eur J Intern Med 2006; 17: 325-329 [PMID: 16864006 DOI: 10. 1016/j. ejim. 2006. 02. 004]
197. Omland LH, Farkas DK, Jepsen P, Obel N, Pedersen L. Hepatitis C virus infection and risk of cancer: a population-based cohort study. Clin Epidemiol 2010; 2: 179-186 [PMID: 20865115]
198. Budako?lu B, Aksoy S, Arslan Ç, Üyetürk Ü, Babacan NA, Özcan MF, Y?ld?z R, Öven BB, Özdemir NY, Dizdar Ö, Büyükberber S, Ak?nc MB, Türker I, Öksüzo?lu B, Altundag K, Zengin N. Frequency of HCV infection in renal cell carcinoma patients. Med Oncol 2012; 29: 1892-1895 [PMID: 21461964 DOI: 10. 1007/ s12032-011-9928-6]
199. Gonzalez HC, Lamerato L, Rogers CG, Gordon SC. Chronic hepatitis C infection as a risk factor for renal cell carcinoma. Dig Dis Sci 2015; 60: 1820-1824 [PMID: 25592719 DOI: 10. 1007/ s10620-015-3521-3]
200. Gordon SC, Moonka D, Brown KA, Rogers C, Huang MA, Bhatt N, Lamerato L. Risk for renal cell carcinoma in chronic hepatitis C infection. Cancer Epidemiol Biomarkers Prev 2010; 19: 1066-1073 [PMID: 20332260]
201. Hofmann JN, Törner A, Chow WH, Ye W, Purdue MP, Duberg AS. Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden. Eur J Cancer Prev 2011; 20: 326-330 [PMID: 21386707 DOI: 10. 1097/CEJ. 0b013e32834572fa]
202. Bruno G, Andreozzi P, Graf U, Santangelo G. Hepatitis C virus: a high risk factor for a second primary malignancy besides hepatocellular carcinoma. Fact or fiction? Clin Ter 1999; 150: 413-418 [PMID: 10756661]
203. Macleod LC, Hotaling JM, Wright JL, Davenport MT, Gore JL, Harper J, White E. Risk factors for renal cell carcinoma in the VITAL study. J Urol 2013; 190: 1657-1661 [PMID: 23665301 DOI: 10. 1016/j. juro. 2013. 04. 130]
204. Xu JH, Fu JJ, Wang XL, Zhu JY, Ye XH, Chen SD. Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies. World J Gastroenterol 2013; 19: 4234-4241 [PMID: 23864789 DOI: 10. 3748/wjg. v19. i26. 4234]
205. Ben Q, Li Z, Liu C, Cai Q, Yuan Y, Wang K, Xiao L, Gao J, Zhang H. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China. Pancreas 2012; 41: 435-440 [PMID: 22422136 DOI: 10. 1097/MPA. 0b013e31822ca176]
206. Chang MC, Chen CH, Liang JD, Tien YW, Hsu C, Wong JM, Chang YT. Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma. World J Gastroenterol 2014; 20: 5060-5065 [PMID: 24803819 DOI: 10. 3748/wjg. v20. i17. 5060]
207. Hassan MM, Li D, El-Deeb AS, Wolff RA, Bondy ML, Davila M, Abbruzzese JL. Association between hepatitis B virus and pancreatic cancer. J Clin Oncol 2008; 26: 4557-4562 [PMID: 18824707 DOI: 10. 1200/JCO. 2008. 17. 3526]
208. Huang J, Magnusson M, Törner A, Ye W, Duberg AS. Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden. Br J Cancer 2013; 109: 2917-2923 [PMID: 24178755 DOI: 10. 1038/bjc. 2013. 689]
209. Woo SM, Joo J, Lee WJ, Park SJ, Han SS, Kim TH, Koh YH, Kim HB, Hong EK. Risk of pancreatic cancer in relation to ABO blood group and hepatitis C virus infection in Korea: a case-control study. J Korean Med Sci 2013; 28: 247-251 [PMID: 23400555 DOI: 10. 3346/jkms. 2013. 28. 2. 247]
210. Zhu F, Li HR, Du GN, Chen JH, Cai SR. Chronic hepatitis B virus infection and pancreatic cancer: a case-control study in southern China. Asian Pac J Cancer Prev 2011; 12: 1405-1408 [PMID: 22126472]
211. Fiorino S, Chili E, Bacchi-Reggiani L, Masetti M, Deleonardi G, Grondona AG, Silvestri T, Magrini E, Zanini N, Cuppini A, Nardi R, Jovine E. Association between hepatitis B or hepatitis C virus infection and risk of pancreatic adenocarcinoma development: a systematic review and meta-analysis. Pancreatology 2013; 13: 147-160 [PMID: 23561973 DOI: 10. 1016/j. pan. 2013. 01. 005]
212. Xing S, Li ZW, Tian YF, Zhang LM, Li MQ, Zhou P. Chronic hepatitis virus infection increases the risk of pancreatic cancer: a meta-analysis. Hepatobiliary Pancreat Dis Int 2013; 12: 575-583 [PMID: 24322741]
213. Hong SG, Kim JH, Lee YS, Yoon E, Lee HJ, Hwang JK, Jung ES, Joo MK, Jung YK, Yeon JE, Park JJ, Kim JS, Bak YT, Byun KS. The relationship between hepatitis B virus infection and the incidence of pancreatic cancer: a retrospective case-control study. Korean J Hepatol 2010; 16: 49-56 [PMID: 20375642 DOI: 10. 3350/ kjhep. 2010. 16. 1. 49]
214. Xu P, Huang Q, Liu C, Xie F, Shao F, Zhu C. Risk factors for pancreatic cancer: a case-control study. Aizheng 2011; 31: 653-657
215. Antonelli A, Ferri C, Fallahi P, Nesti C, Zignego AL, Maccheroni M. Thyroid cancer in HCV-related mixed cryoglobulinemia patients. Clin Exp Rheumatol 2002; 20: 693-696 [PMID: 12412202]
216. Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Barani L, Marchi S, Ferrannini E. Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. Thyroid 2007; 17: 447-451 [PMID: 17542674 DOI: 10. 1089/thy. 2006. 0194]
217. Montella M, Pezzullo L, Crispo A, Izzo F, Amore A, Marone U, Tamburini M, Ronga D, Chiofalo MG, Chiappetta G, Mozzillo N. Risk of thyroid cancer and high prevalence of hepatitis C virus. Oncol Rep 2003; 10: 133-136 [PMID: 12469158]
218. Larrey D, Bozonnat MC, Kain I, Pageaux GP, Assenat E. Is chronic hepatitis C virus infection a risk factor for breast cancer? World J Gastroenterol 2010; 16: 3687-3691 [PMID: 20677341]
219. Su FH, Chang SN, Chen PC, Sung FC, Su CT, Yeh CC. Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study. BMC Cancer 2011; 11: 495 [PMID: 22115285 DOI: 10. 1186/1471-2407-11-495]
220. Amin J, Gidding H, Gilbert G, Backhouse J, Kaldor J, Dore G, Burgess M. Hepatitis C prevalence-a nationwide serosurvey. Commun Dis Intell Q Rep 2004; 28: 517-521 [PMID: 15745402]
221. Eftekharian A, Khajavi M, Shokoofi S, Rahmani Z, Gachkar L, Gerami H, Rajati M, Khademi B. Hepatitis C virus in patients with squamous cell carcinoma of the head and neck in Iran: is there any relation? Eur Arch Otorhinolaryngol 2012; 269: 2571-2573 [PMID: 22331258 DOI: 10. 1007/s00405-012-1953-3]
222. Gandolfo S, Richiardi L, Carrozzo M, Broccoletti R, Carbone M, Pagano M, Vestita C, Rosso S, Merletti F. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol 2004; 40: 77-83 [PMID: 14662419]
223. Nagao Y, Sata M, Noguchi S, Seno'o T, Kinoshita M, Kameyama T, Ueno T. Detection of hepatitis C virus RNA in oral lichen planus and oral cancer tissues. J Oral Pathol Med 2000; 29: 259-266 [PMID: 10890556]
224. Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T. High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. J Oral Pathol Med 1995; 24: 354-360 [PMID: 7500291]
225. Nobles J, Wold C, Fazekas-May M, Gilbert J, Friedlander PL. Prevalence and epidemiology of hepatitis C virus in patients with squamous cell carcinoma of the head and neck. Laryngoscope 2004; 114: 2119-2122 [PMID: 15564831 DOI: 10. 1097/01. mlg. 0000149444. 30017. e8]
226. Su FH, Chang SN, Chen PC, Sung FC, Huang SF, Chiou HY, Su CT, Lin CC, Yeh CC. Positive association between hepatitis C infection and oral cavity cancer: a nationwide population-based cohort study in Taiwan. PLoS One 2012; 7: e48109 [PMID: 23133554 DOI: 10. 1371/journal. pone. 0048109]
227. Takata Y, Takahashi T, Fukuda J. Prevalence of hepatitis virus infection in association with oral diseases requiring surgery. Oral Dis 2002; 8: 95-99 [PMID: 11991310]
228. Hunt J, Hagan J, Nobles J, Wold C, Fazekas-May M, Gilbert J, Friedlander PL. Outcome analysis of patients with squamous cell carcinoma of the head and neck and hepatitis C virus. Laryngoscope 2005; 115: 1882-1886 [PMID: 16222215 DOI: 10. 1097/01. mlg. 0000177991. 03841. 27]
229. International Agency for Research on Cancer. Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization, 2012
230. Alvares-Da-Silva MR, Francisconi CF, Waechter FL. Acute hepatitis C complicated by pancreatitis: another extrahepatic manifestation of hepatitis C virus? J Viral Hepat 2000; 7: 84-86 [PMID: 10718948]
231. Richardson A. Is breast cancer caused by late exposure to a common virus? Med Hypotheses 1997; 48: 491-497 [PMID: 9247892]
232. Yasui Y, Potter JD, Stanford JL, Rossing MA, Winget MD, Bronner M, Daling J. Breast cancer risk and "delayed" primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev 2001; 10: 9-16 [PMID: 11205495]
233. Tsui JI, Vittinghoff E, Shlipak MG, Bertenthal D, Inadomi J, Rodriguez RA, O'Hare AM. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med 2007; 167: 1271-1276 [PMID: 17592100 DOI: 10. 1001/ archinte. 167. 12. 1271]
234. Fayek S, Moore D, Bortecen KH, Yeh H, Markmann JF, Olthoff KM, Shaked A. Liver transplantation in the setting of extra-hepatic malignancy: two case reports. Transplant Proc 2007; 39: 3512-3514 [PMID: 18089424 DOI: 10. 1016/j. transproceed. 2007. 09. 007]
235. Garcia JH, Coelho GR, Cavalcante FP, Valença JT, Brasil IR, Cesar-Borges G, Costa PE, Viana CF, Rocha TD, Vasconcelos JB. Synchronous hepatocellular carcinoma and renal cell carcinoma in a liver transplant recipient: a case report. Transplantation 2007; 84: 1713 [PMID: 18165787 DOI: 10. 1097/01. tp. 0000296469. 78853. 83]
236. Di Micco B, Di Micco P. HCV and renal cell carcinoma: a new insight between HCV and oncogenesis? Report of five cases. Experimental Oncology 2003; 25: 77-78
237. Nagao Y, Sata M, Itoh K, Chiba I, Komiyama K, Yanoma S, Eura M, Tanikawa K, Kameyama T. High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma. Hepatology Research 1997; 7: 206-212
238. Carrozzo M, Carbone M, Gandolfo S, Valente G, Colombatto P, Ghisetti V. An atypical verrucous carcinoma of the tongue arising in a patient with oral lichen planus associated with hepatitis C virus infection. Oral Oncol 1997; 33: 220-225 [PMID: 9307733]
239. Lo Muzio L, Mignogna MD, Favia G, Procaccini M, Testa NF, Bucci E. The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. Oral Oncol 1998; 34: 239-246 [PMID: 9813716]
240. Campisi G, Fedele S, Lo Russo L, Di Fede O, Aricò P, Craxì A, Mignogna MD. HCV infection and oral lichen planus: a weak association when HCV is endemic. J Viral Hepat 2004; 11: 465-470 [PMID: 15357654 DOI: 10. 1111/j. 1365-2893. 2004. 00532. x]
241. Birkenfeld S, Dreiher J, Weitzman D, Cohen AD. A study on the association with hepatitis B and hepatitis C in 1557 patients with lichen planus. J Eur Acad Dermatol Venereol 2011; 25: 436-440 [PMID: 20666875 DOI: 10. 1111/j. 1468-3083. 2010. 03809. x]
242. Lodi G, Olsen I, Piattelli A, D'Amico E, Artese L, Porter SR. Antibodies to epithelial components in oral lichen planus (OLP) associated with hepatitis C virus (HCV) infection. J Oral Pathol Med 1997; 26: 36-39 [PMID: 9021550]
243. Petti S, Rabiei M, De Luca M, Scully C. The magnitude of the association between hepatitis C virus infection and oral lichen planus: meta-analysis and case control study. Odontology 2011; 99: 168-178 [PMID: 21505737 DOI: 10. 1007/s10266-011-0008-3]
244. Shengyuan L, Songpo Y, Wen W, Wenjing T, Haitao Z, Binyou W. Hepatitis C virus and lichen planus: a reciprocal association determined by a meta-analysis. Arch Dermatol 2009; 145: 1040-1047 [PMID: 19770446 DOI: 10. 1001/archdermatol. 2009. 200]
245. Carrozzo M, Gandolfo S. Oral diseases possibly associated with hepatitis C virus. Crit Rev Oral Biol Med 2003; 14: 115-127 [PMID: 12764074]
246. Antonelli A, Ferri C, Fallahi P. Thyroid cancer in patients with hepatitis C infection. JAMA 1999; 281: 1588 [PMID: 10235149]
247. Montella M, Crispo A, Pezzullo L, Izzo F, Fabbrocini G, Ronga D, Tamburini M. Is hepatitis C virus infection associated with thyroid cancer? A case-control study. Int J Cancer 2000; 87: 611-612 [PMID: 10918206 DOI: 10. 1002/1097-0215(20000815)87: ]
248. Chen CJ, Hsu WL, Yang HI, Lee MH, Chen HC, Chien YC, You SL. Epidemiology of virus infection and human cancer. Recent Results Cancer Res 2014; 193: 11-32 [PMID: 24008291 DOI: 10. 10 07/978-3-642-38965-82]
249. Fiorino S, Bacchi-Reggiani L, Pontoriero L, Gallo C, Chili E, Masetti M, Zanini N, Grondona A, Silvestri T, Deleonardi G, Magrini E, Motta R, Fornelli A, Bondi A, de Biase D, Baccarini P, Tallini G, Tropeano A, Cuppini A, Castellani G, Jovine E. Pancreatic carcinoma development: new etiological and pathogenetic evidence. Italian J Med 2013; 7: 242-252
250. Andreone P, Zignego AL, Cursaro C, Gramenzi A, Gherlinzoni F, Fiorino S, Giannini C, Boni P, Sabattini E, Pileri S, Tura S, Bernardi M. Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. Ann Intern Med 1998; 129: 294-298 [PMID: 9729182]
251. Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, Trichopoulos D, Vilstrup H, Olsen J. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 1998; 28: 921-925 [PMID: 9755226 DOI: 10. 1002/hep. 510280404]
252. Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol 2013; 59: 169-177 [PMID: 23542089 DOI: 10. 1016/j. jhep. 2013. 03. 018]
253. Zaret KS. Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation. Nat Rev Genet 2008; 9: 329-340 [PMID: 18398419 DOI: 10. 1038/nrg2318]
254. Wandzioch E, Zaret KS. Dynamic signaling network for the specification of embryonic pancreas and liver progenitors. Science 2009; 324: 1707-1710 [PMID: 19556507 DOI: 10. 1126/ science. 1174497]
255. Huxley R, Ansary-Moghaddam A, Berrington de González A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a metaanalysis of 36 studies. Br J Cancer 2005; 92: 2076-2083 [PMID: 15886696 DOI: 10. 1038/sj. bjc. 6602619]
256. Li D. Diabetes and pancreatic cancer. Mol Carcinog 2012; 51: 64-74 [PMID: 22162232 DOI: 10. 1002/mc. 20771]
257. Chow YW, Pietranico R, Mukerji A. Studies of oxygen binding energy to hemoglobin molecule. Biochem Biophys Res Commun 1975; 66: 1424-1431 [PMID: 6 DOI: 10. 2337/dc10-066]
258. Han L, Ma Q, Li J, Liu H, Li W, Ma G, Xu Q, Zhou S, Wu E. High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. PLoS One 2011; 6: e27074 [PMID: 22087246 DOI: 10. 1371/journal. pone. 0027074]
259. Li J, Ma Q, Liu H, Guo K, Li F, Li W, Han L, Wang F, Wu E. Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia. PLoS One 2011; 6: e17385 [PMID: 21386984 DOI: 10. 1371/journal. pone. 0017385]
260. Liao WC, Tu YK, Wu MS, Lin JT, Wang HP, Chien KL. Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ 2015; 349: g7371 [PMID: 25556126 DOI: 10. 1136/bmj. g7371]
261. White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol 2008; 49: 831-844 [PMID: 18814931 DOI: 10. 1016/j. jhep. 2008. 08. 006]
262. Naing C, Mak JW, Ahmed SI, Maung M. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: metaanalysis. World J Gastroenterol 2012; 18: 1642-1651 [PMID: 22529694 DOI: 10. 3748/wjg. v18. i14. 1642]
263. Tanaka H, Imai Y, Hiramatsu N, Ito Y, Imanaka K, Oshita M, Hijioka T, Katayama K, Yabuuchi I, Yoshihara H, Inoue A, Kato M, Takehara T, Tamura S, Kasahara A, Hayashi N, Tsukuma H. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med 2008; 148: 820-826 [PMID: 18519928]
264. McGlynn KA, Tarone RE, El-Serag HB. A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2006; 15: 1198-1203 [PMID: 16775181 DOI: 10. 1158/1055-9965. EPI-05-0811]
265. Ito M, Murakami K, Suzuki T, Mochida K, Suzuki M, Ikebuchi K, Yamaguchi K, Mizuochi T. Enhanced expression of lymphomagenesis-related genes in peripheral blood B cells of chronic hepatitis C patients. Clin Immunol 2010; 135: 459-465 [PMID: 20189883 DOI: 10. 1016/j. clim. 2010. 02. 002]
266. Mosad E, Said Abd El-Rahman Allam M, Moustafa HM, Mohammed AE, El kebeer AM, Abdel-Moneim SS. Telomeric 1p36. 3 deletion and Ki-67 expression in B-Non-Hodgkin's Lymphoma patients associated with chronic hepatitis C virus infection. J Viral Hepat 2014; 21: 950-955 [PMID: 25158783 DOI: 10. 1111/jvh. 12304]
267. Smedley D, Sidhar S, Birdsall S, Bennett D, Herlyn M, Cooper C, Shipley J. Characterization of chromosome 1 abnormalities in malignant melanomas. Genes Chromosomes Cancer 2000; 28: 121-125 [PMID: 10738310 DOI: 10. 1002/(SICI)1098-2264(20000 5)28:1]
268. Stoffel A, Filippa D, Rao PH. The p73 locus is commonly deleted in non-Hodgkin's lymphomas. Leuk Res 2004; 28: 1341-1345 [PMID: 15475076 DOI: 10. 1016/j. leukres. 2004. 04. 010]